KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Michael Kauffman on Q3 2020 Results - Earnings Call Transcript

Karyopharm Therapeutics, Inc. (KPTI) Q3 2020 Earnings Conference Call November 2, 2020 4:30 p.m. ET Company Participants Ian Karp - VP, Investor and Public Relations Michael Kauffman - CEO Sharon Shacham - President and Chief Scientific Officer Mike Mason - CFO John Demaree - Chief Commercial Officer Christopher Primiano - Chief Business Officer and General Counsel Jatin Shah - Chief Medical Officer Conference Call Participants Jonathan Chang - SVB Leerink Maury Raycroft - Jefferies Brian Abrahams - RBC Capital Markets Eric Joseph - J.P. Morgan David Lebowitz - Morgan Stanley Michael Ulz - Robert W. Baird Edward White - H.C. Wainwright Peter Lawson - Barclays Capital Presentation Operator Good afternoon. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to Karyopharm Therapeutics' Third Quarter 2020 Financial Results Conference Call. [Operator Instructions] Please be advised that the call is

For further details see:

Karyopharm Therapeutics, Inc. (KPTI) CEO Michael Kauffman on Q3 2020 Results - Earnings Call Transcript